Published on 25.01.19 in Vol 6, No 1 (2019): January
Preprints (earlier versions) of this paper are available at http://preprints.jmir.org/preprint/11334, first published Jun 18, 2018.
Adoption of Mobile Apps for Depression and Anxiety: Cross-Sectional Survey Study on Patient Interest and Barriers to Engagement
Background: Emerging research suggests that mobile apps can be used to effectively treat common mental illnesses like depression and anxiety. Despite promising efficacy results and ease of access to these interventions, adoption of mobile health (mHealth; mobile device–delivered) interventions for mental illness has been limited. More insight into patients’ perspectives on mHealth interventions is required to create effective implementation strategies and to adapt existing interventions to facilitate higher rates of adoption.
Objective: The aim of this study was to examine, from the patient perspective, current use and factors that may impact the use of mHealth interventions for mental illness.
Methods: This was a cross-sectional survey study of veterans who had attended an appointment at a single Veterans Health Administration facility in early 2016 that was associated with one of the following mental health concerns: unipolar depression, any anxiety disorder, or posttraumatic stress disorder. We used the Veteran Affairs Corporate Data Warehouse to create subsets of eligible participants demographically stratified by gender (male or female) and minority status (white or nonwhite). From each subset, 100 participants were selected at random and mailed a paper survey with items addressing the demographics, overall health, mental health, technology ownership or use, interest in mobile app interventions for mental illness, reasons for use or nonuse, and interest in specific features of mobile apps for mental illness.
Results: Of the 400 potential participants, 149 (37.3%, 149/400) completed and returned a survey. Most participants (79.9%, 119/149) reported that they owned a smart device and that they use apps in general (71.1%, 106/149). Most participants (73.1%, 87/149) reported interest in using an app for mental illness, but only 10.7% (16/149) had done so. Paired samples t tests indicated that ratings of interest in using an app recommended by a clinician were significantly greater than general interest ratings and even greater when the recommending clinician was a specialty mental health provider. The most frequent concerns related to using an app for mental illness were lacking proof of efficacy (71.8%, 107/149), concerns about data privacy (59.1%, 88/149), and not knowing where to find such an app (51.0%, 76/149). Participants expressed interest in a number of app features with particularly high-interest ratings for context-sensitive apps (85.2%, 127/149), and apps focused on the following areas: increasing exercise (75.8%, 113/149), improving sleep (73.2%, 109/149), changing negative thinking (70.5%, 105/149), and increasing involvement in activities (67.1%, 100/149).
Conclusions: Most respondents had access to devices to use mobile apps for mental illness, already used apps for other purposes, and were interested in mobile apps for mental illness. Key factors that may improve adoption include provider endorsement, greater publicity of efficacious apps, and clear messaging about efficacy and privacy of information. Finally, multifaceted apps that address a range of concerns, from sleep to negative thought patterns, may be best received.
JMIR Ment Health 2019;6(1):e11334
The majority of the US population owns smartphones (77% in 2016) , and the number of mobile apps for health has grown exponentially over the past decade. A study by the IMS Institute for Healthcare Informatics [ ] found that the number of health and wellness apps available to consumers has more than doubled between 2013 and 2015 (from 43,000 to over 90,000). Although the content and quality of these apps vary widely, the potential public health impact of such tools is enormous. Research suggests that mobile health (mHealth) interventions can have a positive influence on a wide range of health conditions [ , ] and, while not a substitute for in-person treatment, these tools offer a treatment option that does not have as many access barriers as in-office treatment (eg, no transportation is required) and may allow for reduced cost of care (since marginal cost is negligible).
In mental illness—where stigma and self-reliance beliefs are additional barriers to treatment seeking and engagement —mobile health (mHealth) offers even greater potential. Common mental health disorders such as depression and anxiety impact nearly a third of the US population, and most of those who need treatment do not receive it [ , ]. The sheer number of people affected makes providing adequate treatment in traditional clinical settings prohibitive in terms of availability of trained providers. Studies indicate that mHealth interventions can improve functioning and symptoms in those with depression and/or anxiety [ - ] and also that technology offers some advantages over in-person treatments. Specifically, mHealth interventions offer 24/7 support because mobile devices are often kept with users throughout the day. In addition, patients may be more likely to report severe symptoms on technology platforms than in person [ ], and patients value the autonomy and empowerment that can be offered by such platforms [ ].
Unfortunately, adoption of mHealth interventions for common mental illnesses such as depression and anxiety remains low. To date, mHealth is neither a routine part of mental health care offerings in the United States nor has any mHealth platform for mental illness been widely adopted by consumers in the United States. These patterns are particularly noteworthy in systems such as the Veterans Health Administration (VHA), which has invested substantially in building and evaluating several free behavioral health apps specifically designed for mental health concerns of veterans. Several theoretical models explaining technology adoption and continued use have been put forth in the literature [- ]. Existing models have some conflicting and some overlapping components and have been found to explain as little as 17% and as much as 53% of the variance in adoption [ ]. Newer unified models may explain more of the variance in adoption and use, but much of this literature has traditionally focused largely on adoption of technology in the workplace, a considerably different context than the treatment of mental illness. This multifaceted theoretical canvas underscores the complexity of understanding adoption and the potential importance of studying specific types of technology within the intended use population. At present, it is unclear what are the best approaches for encouraging patient adoption of mHealth interventions.
Research on patient adoption of technology in treatment of mental illness suggests that interest outpaces adoption. Specifically, studies of patients with depression, anxiety, and posttraumatic stress disorder (PTSD) suggest that interest varies widely based on the type of technology in question, but most patients are interested in using some kinds of technology in treatment [, ]. With regard to mHealth specifically, Erbes et al [ ] found that over half of a sample of patients with PTSD expressed interest in mHealth programs for PTSD, but less than 10% were currently using these platforms to help manage their symptoms.
Given high interest and low adoption, there is a need to build a stronger understanding of the factors that may affect adoption at the system level. Research on other patient-facing technologies suggests that how such technologies are integrated into the health care system may impact patient adoption. For example, findings from studies focused on adoption of one Web portal indicate that provider endorsement can improve rates of adoption . It remains to be determined whether this is the case for mHealth interventions.
There is also a need to build a stronger understanding of factors that may affect adoption at the patient level. A large national survey of health app use in the general population indicated that lack of interest, cost, and concern about data privacy were key barriers to adoption . These findings have been reinforced in other studies focused on mental health apps. Specifically, a study focused on mHealth interventions for depression found that cost, concerns about privacy, concerns over intervention efficacy, and misfit of intervention features to needs (ie, personalization) were key barriers to adoption of depression apps [ ]. Another study focused on health and mental health apps found that efficacy and privacy are key barriers to adoption as well as not knowing where to find an app or knowing which app to download [ ]. However, these studies were conducted using only partially clinical samples, that is, presence of clinically significant symptoms (on self-report or via medical record diagnosis) was either not an eligibility criterion or not assessed.
Stronger understanding of patient perspectives on mHealth interventions in relevant clinical samples is required to support the development of targeted implementation strategies and platform modifications that will ultimately promote adoption. The aim of this study was to characterize mHealth interest, concerns, and preferences in a sample of patients with an active diagnosis of depression, anxiety, and/or PTSD. Specifically, we sought to (1) identify patients’ degree of interest in mHealth interventions for mental health, (2) identify whether provider endorsement would impact degree of interest, (3) determine reasons for nonuse of mHealth interventions for mental health, and (4) identify what mHealth content or features are of most interest to patients.
We used the Veterans Affairs (VA) Corporate Data Warehouse (CDW) to identify individuals meeting eligibility criteria and to extract contact and diagnostic information for those individuals. Eligibility criteria were as follows: (1) US military veteran enrolled in care at the VA Boston Healthcare System; (2) receiving VA primary care, as indicated by having at least one encounter in the local primary care clinic between January 1, 2016, and July 1, 2016; (3) aged 18 years or older; and (4) attended a VA medical appointment between January 1, 2016, and July 1, 2016, in which an anxiety disorder (including obsessive-compulsive disorder), unipolar depressive disorder, or PTSD was documented as a condition treated in the appointment. Codes based on the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10) were used to determine visits associated with unipolar depression (F32-F34) and anxiety and PTSD (F40-F43). The decision to include patients with any or all of these diagnoses in the sample was based on high comorbidity rates between these diagnoses and the similarity of pharmacological and psychotherapeutic treatments for these disorders [- ].
A total of 2840 veterans in the CDW met the above criteria. Within this sample, we divided records into 4 strata (white men, nonwhite men, white women, and nonwhite women) and randomly sampled 100 records from each stratum to achieve a gender- and minority-balanced set of potential participants. These randomly selected 400 individuals were actively recruited for participation via mailed surveys and accompanying study information. Although electronic medical record diagnostic codes were used to define our CDW search parameters and establish a set of eligible participants, these codes were not extracted for use in our dataset. This decision was made to protect patients’ privacy, especially those patients who chose not to participate. The only information extracted from patient’s charts was name and mailing address.
We used a modified Dillman method for recruitment . The 400 veterans identified as potential participants were sent a series of 3 mailings, each including a letter inviting the veteran to participate, a study fact sheet, the survey, a postage-marked opt-out postcard, and a postage-marked return envelope. In addition, the first mailing contained a $10 Patron coupon for use at the local VA facility cafeteria and general store. The study invitation letter informed veterans that they may keep this coupon regardless of their decision to participate in this research. Participants who returned either the survey or opt-out postcard were not included in successive mailings.
All recruitment and study procedures were approved by the VA Boston Healthcare System’s institutional review board.
Survey items were a combination of validated measures and newly developed questions based on the literature on technology use and adoption [- ]. As there was no precedent for items evaluating concerns related to mental health app use and/or interest after clinician endorsement, these items were developed based on existing literature and field tested among a diverse team of colleagues with expertise in survey development. Items on mental health app features of interest to participants were selected based on a review of the literature on common elements of depression and anxiety apps [ , ].
The final survey consisted of 38 questions focused on 6 domains: (1) sociodemographic characteristics; (2) physical and mental health symptoms assessed using the SF-1 (first item of the 36-item Short Form Health Survey) for overall health [, ], the Patient Health Questionnaire-8 (PHQ-8) for depression symptom severity [ , ], and Generalized Anxiety Disorder-7 (GAD-7) for anxiety symptom severity [ , , ]; (3) technology ownership and use; (4) interest in apps for mental illness; (5) reasons for not using apps for mental illness; and (6) interest in specific mental illness app features (see for a list of items in each domain).
We aggregated descriptive data on the following: demographic and health characteristics, devices owned, current technology use, and ratings on interest in mHealth interventions.
We used paired sample t tests to evaluate the degree to which provider endorsement impacted participants’ level of interest in use of mHealth interventions for mental illness. Specifically, t tests compared participants’ general interest ratings with those provided when asked how interested they would be in using a mobile app for mental illness if their primary care provider (PCP) recommended it. A similar comparison was conducted between general interest ratings and those provided when asked how interested they would be in using a mobile app for mental illness if their mental health provider recommended the app. Finally, we used t tests to compare interest ratings associated with PCP recommendation with those associated with mental health provider recommendation.
We also compiled aggregate descriptive data on the following: reasons endorsed for using or not using mobile apps for mental health and interest in specific app features and content.
A total of 149 surveys were returned (response rate of 37.3%, 149/400). The resulting sample was fairly balanced on demographic characteristics (see). For clarity and because no item or scale had missing data for more than 8.1% (12/149) of respondents, all results are reported as percentages of the full sample.
The mean PHQ-8 score was 11.25 (SD 6.62), and the majority of the sample (65.8%, 98/149) reported symptoms that met the PHQ-8 cutoff score of 8, indicating clinically significant depressive symptoms . The mean GAD-7 score was 9.65 (SD 6.02), and more than half of the sample (56.4%, 84/149) reported symptoms that met the GAD-7 cutoff score of 8 for clinically significant anxiety symptoms [ , ]. Self-reported mental health conditions were collected and are detailed in .
Technology Ownership and Use
The majority of the participants reported owning a smartphone (75.8%, 113/149) and a smaller portion reported owning a tablet (45.6%, 68/149). Together, a total of 119 participants (79.9%, 119/149) reported owning a smart device that could be used to run a mental health app.displays participant answers with regard to current app and smart device technology use.
Interest in Apps for Mental Illness
When asked how interested they would be in using an app for mental illness, 73.1% (87/149) reported some level of interest. Specifically, 12.8% (19/149) indicated that they would be completely interested, 22.1% (33/149) indicated that they would be very interested, 22.8% (34/149) indicated that they would be moderately interested, and 15.4% (23/149) indicated that they would be a little interested. When the sample was limited to only those who owned a smart device, the percentage of individuals with some level of interest in using an app for mental illness was slightly higher (77.3%, 92/149).
In addition, when asked about interest in apps that could deliver context-sensitive feedback (ie, utilizing passive sensors to respond to physical or behavioral changes), the majority of the sample (84.0%, 125/149) reported some interest. Specifically, 28.9% (43/149) reported that they would be completely interested, 26.2% (39/149) reported that they would be very interested, 16.1% (24/149) reported that they would be moderately interested, and 12.8% (19/149) reported that they would be a little interested. When the sample was limited to only those who owned a smart device, the percentage of individuals interested in an app that delivered context-sensitive feedback was only slightly higher (86.6%, 103/149).
Relationship Between Interest in Apps for Mental Illness and Provider Endorsement
Paired sample t tests were used to determine whether provider endorsement would impact interest levels. Starting with an alpha=.05 as the critical P value, the Bonferroni corrected P value for 3 t tests was .017. Participants rated global interest independent of provider endorsement (mean 2.81 [SD 1.38]) significantly lower than interest in the context of PCP endorsement (mean 3.13 [SD 1.38], t147=−5.65, P<.001, d=0.23). Similarly, participants rated global interest independent of provider endorsement (mean 2.81 [SD 1.38]) significantly lower than interest in the context of mental health provider endorsement (mean 3.30 [SD 1.36], t145=−4.05, P<.001, d=0.36). Finally, participants rated interest in the context of PCP endorsement (mean 3.13 [SD 1.38]) significantly lower than interest in the context of mental health provider endorsement (mean 3.30 [SD 1.36], t145=−3.37, P<.001, d=0.12). When the sample was limited to only those who owned smart devices (n=119), these comparisons remained significant at the P<.001 level in the same directions.
Reasons for Not Using Apps for Mental Illness
displays the frequency with which participants endorsed specific reasons for not using mental health apps. The most commonly endorsed reasons were not having proof that the app would work, concerns about privacy, and not knowing where to find such an app. These were the most commonly endorsed reasons both when the full sample was considered and when the sample was limited to only those participants who owned smart devices.
Interest in Specific Mental Illness App Features
displays the frequency with which participants endorsed interest in features of mental health apps. The features with the highest interest ratings related to increasing exercise, getting better sleep, cognitive restructuring (changing negative or self-critical thinking), and behavioral activation (getting involved in more activities). These features were the most frequently endorsed both when the full sample was considered and when the sample was limited to only those participants who owned smart devices.
|Age (years), mean (SD)||57.5 (13.9)|
|Gender, n (%)|
|Not reported||5 (3.4)|
|Race or ethnicity, n (%)|
|Caucasian or white||67 (45.0)|
|African American or black||44 (29.5)|
|Hispanic or Latino||9 (6.0)|
|Not reported||7 (4.7)|
|American Indian, Alaskan Native||4 (2.7)|
|Pacific Islander||1 (0.7)|
|Education, n (%)|
|Middle school (7th-8th)||1 (0.7)|
|High school (9th-12th)||24 (16.1)|
|Some college or vocational school||41 (27.5)|
|Associates degree (2-year college)||16 (10.7)|
|Bachelor’s degree (4-year college or university)||36 (24.2)|
|Graduate degree||27 (18.1)|
|Not reported||4 (2.7)|
|English as first language, n (%)||134 (89.9)|
|Marital status, n (%)|
|Divorced or separated||49 (32.9)|
|Single, never married||39 (26.2)|
|Not reported||4 (2.7)|
|Annual household income, n (%)|
|Less than US $20,000||36 (24.2)|
|US $20,000 to US $34,999||21 (14.1)|
|US $35,000 to US $49,999||35 (23.5)|
|US $50,000 to US $74,999||20 (13.4)|
|US $75,000 to US $99,999||15 (10.1)|
|US $100,000 to US $149,999||8 (5.4)|
|US $150,000 or more||2 (1.3)|
|Not reported||12 (8.1)|
|Self-reported health rating, n (%)|
|Very good||21 (14.1)|
|Not reported||6 (4.0)|
|Self-reported behavioral health conditions, n (%)|
|Difficulty sleeping||93 (62.4)|
|Posttraumatic stress disorder||91 (61.1)|
|Chronic pain||88 (59.1)|
|Substance use disorder (not alcohol)||15 (10.1)|
|Alcohol use disorder||14 (9.4)|
|Type of technology use||Frequency endorsed, n (%)|
|Smartphone or tablet functions|
|Taking pictures or camera||116 (77.9)|
|Searching the internet||104 (69.8)|
|Checking the weather forecast||103 (69.1)|
|Driving or walking directions||95 (63.8)|
|Social media||83 (55.7)|
|Use of apps for other health-related goals|
|Daily steps||42 (28.2)|
|Tracking calories||34 (22.8)|
|Mindfulness exercises||31 (20.8)|
|Weight management||30 (20.1)|
|Mental illness||16 (10.7)|
|Reason||Smart device owners (n=119), n (%)||Full sample (N=149), n (%)|
|I might use an app for these problems if I saw proof that it worked.||92 (77.3)||107 (71.8)|
|I am concerned about protecting my privacy with having my information in an app like this.||73 (61.3)||88 (59.1)|
|I don’t know how to find an app that would help.||61 (51.3)||76 (51.0)|
|I don’t think an app can help me to get better.||44 (37.0)||55 (36.9)|
|I am already in treatment for stress, depression, anxiety or PTSDa and don’t see the need for an app.||43 (36.1)||52 (34.9)|
|It would be embarrassing to have an app like this on my phone.||31 (26.1)||39 (26.2)|
|I don’t use apps at all.||13 (10.9)||29 (19.5)|
|I tried an app like this before and did not like it because it was not personalized enough.||13 (10.9)||14 (9.4)|
|I don’t think I have a problem with stress, depression, anxiety or PTSD.||12 (10.1)||21 (14.1)|
|I tried an app like this before and it did not help.||11 (9.2)||11 (7.4)|
|I tried an app like this before and did not like it because it was difficult to use.||10 (8.4)||12 (8.1)|
aPTSD: posttraumatic stress disorder.
|Item wording (intervention label)||Smart device owners (n=119), n (%)||Full sample (N=149), n (%)|
|Increase your physical activity or exercise (physical activity)||95 (79.8)||113 (75.8)|
|Help you learn to get better sleep (Cognitive Behavioral Therapy for Insomnia)||87 (73.1)||109 (73.2)|
|Learn how to change negative/self-critical thinking (cognitive restructuring)||86 (72.3)||105 (70.5)|
|Get involved in more activities (behavioral activation)||86 (72.3)||100 (67.1)|
|Track mood/stress/anxiety/PTSDa symptoms (progress monitoring)||80 (67.2)||95 (63.8)|
|Speak with a health coach when your symptoms are bad. (professional support)||79 (66.4)||98 (65.8)|
|Learn more about your mental health condition. (psychoeducation)||77 (64.7)||92 (61.7)|
|Help improve your social skills (social skills training)||75 (63.0)||92 (61.7)|
|Remind you to take your medications. (medication adherence)||73 (61.3)||91 (61.1)|
|Connect with a community of people with similar mental health problems (social support)||61 (51.3)||72 (48.3)|
aPTSD: posttraumatic stress disorder.
Results from this study indicate that access and interest in mobile apps for mental illness outpace actual use. Specifically, we found that access to devices and use of apps, in general, was high: nearly 80% of our sample reported owning smart devices, and of those with smart devices, nearly 90% reported that they use apps. Interest in using mobile apps for mental illness was also high: over 70% of the sample indicated that they have some level of interest. Despite owning the requisite devices, having active and relevant diagnoses (as indicated by PHQ-8 and GAD-7 scores), and expressing interest, use of mobile apps for mental illness was low: only 1 in 10 participants used apps for mental illness. These findings could be interpreted as indicating that most participants wanted to use mHealth interventions for mental illness and had the device and technology knowledge to do so.
Findings also provide some guidance into factors that may impact adoption. First, the highest-rated reasons for not using apps for mental health were related to not having proof of efficacy, concerns about whether these apps could keep mental health information adequately private, and not knowing where to find such an app. These findings suggest that public dissemination of information on efficacy of apps for mental illness (eg, in doctors’ offices or on public transportation) could improve adoption. Moreover, informing users how information within the app is protected (eg, in the introductory screens of the app) may increase adoption. Concerns related to efficacy and privacy are supported by earlier studies [, , ], but until recently [ ], lack of information on where to find evidence-based apps has not been clearly articulated as a barrier to adoption. With regard to barriers to adoption, it is important to specifically note that this study did not evaluate cost as a barrier to adoption for 2 reasons. First, within VA, cost concerns of medical care are different than outside VA. Second, VA has developed a number of mobile apps for mental illness that are freely available to the public and relevant for the veterans recruited in this study.
Provider endorsement also appears to be a promising avenue for increasing adoption of mHealth for mental illness. Participants provided significantly higher interest ratings in the context of provider endorsement than when asked more generally about interest in using such apps. These findings are consistent with existing literature on the impact of provider endorsement in patient adoption of other patient-facing technologies (eg, patient portals that offer messaging and other features) . These findings go beyond the existing literature, however, by showing that the type of provider endorsing the intervention may matter because interest ratings were greater in the context of mental health provider endorsement than PCP endorsement. Provider recommendation is not currently the norm; recent research suggests that individuals are more likely to hear about mental health apps through social media, Web searches, or friends than through medical providers [ ]. Findings from our study underscore that providers could potentially play a key role in increasing adoption. Findings also raise questions about who among providers should be endorsing mHealth interventions to maximize the chances of adoption.
Although this study did not seek to directly test existing models of technology adoption, some interesting parallels between these findings and existing models were observed. Specifically, the Unified Theory of Acceptance and Use of Technology  indicates that 2 key determinants of technology adoption and use are performance expectancy (a user’s beliefs on whether the technology will be helpful) and social influence (how strongly an individual believes that important others think he or she should use the technology). Findings that both proof of efficacy and provider endorsement would encourage use are consistent with these 2 theoretical constructs. Considering the results from this research in relation to such constructs is particularly important to understanding how evolving theories of technology adoption can best be applied in different contexts, including patient adoption of technology and its integration into mental health treatment.
Findings also provide insight into what features and content of apps patients with depression, anxiety, and/or PTSD may find most useful. Over 70% of participants with smart devices reported interest in using apps that facilitate core functions of cognitive behavioral therapy such as cognitive restructuring and behavioral activation. Over 73% of participants with smart devices reported interest in features that would promote wellness in areas of behavioral health such as sleep difficulties and inactivity. These findings suggest that this population may be best served by individual apps or suites of apps that target depression and anxiety from multiple angles .
In addition, interest in context-sensing mobile app interventions was high; 85% of participants indicated some level of interest in this type of intervention. This finding contrasts with other research where participants endorsed skepticism and concern over context sensing . Interest in context-sensing mobile app interventions may indicate an interest in personalization. Along these lines, shows that the majority of those who reported having used an app for mental health also endorsed that they did not like it because it was not sufficiently personalized. This finding should be interpreted with caution because we do not know which apps these participants used, and it is difficult to draw conclusions based on such a small subsample (only 10.7% of the full sample had used apps for mental illness). However, other research corroborates that patient reports of insufficient personalization is a perceived barrier to using mobile treatment apps for depression [ ].
It was also worth noting that although participants endorsed interest in apps that offered the option of speaking to a health coach, 5 other features were endorsed more frequently than this feature. There has been a lot of emphasis on the integration of health coaching into app platforms both as a way to enhance engagement and as a way to produce higher levels of change [, ]. On the other side of this debate, some research indicates that integrating health coaching does not necessarily ensure engagement in technology-based interventions for depression as users can simply ignore calls from coaches [ ]. Findings from this study contribute to this debate and indicate that health coaching capabilities may not be essential for user interest and/or engagement.
Strengths and Limitations
Key strengths of this study include engagement of a racially diverse, clinical sample and proactive recruitment methods. By mailing paper surveys to patients identified as eligible, we expect to have captured data from individuals who may not have responded to more passive recruitment approaches (eg, flyers in waiting rooms). However, our proactively mailed survey methodology also introduces some bias as it is also possible that those who were less interested in use of technology were less likely to respond to the survey. Nevertheless, it is our expectation that the clinical nature of our sample was appropriate for our research questions and that our recruitment method introduced less bias than studies recruiting online or via social media, which essentially make technology proficiency a condition for entry into the study.
The sample in this study consisted entirely of veterans receiving services at a single VA hospital in a metropolitan area in the northeastern United States. Generalizability of findings to nonveteran samples and samples collected in other geographical areas should be tested in future studies. In addition, given the scope and funding level of this study, the presence of diagnoses required for eligibility was based on patients’ medical records and not verified by study staff independently through a structured clinical interview.
Finally, this study evaluated stated preferences and interests. A close-ended question format was used for this survey; however, the downside of survey items formatted in this manner is that they can produce less nuanced data when answer options do not fully capture patients’ thoughts. Additional research that includes more nuanced data collection such as a mixed-methods study with qualitative interviews will be an important next step. Moreover, moving forward, it will be necessary to evaluate whether these self-reported findings hold up behaviorally. That is, future research will need to assess whether implementation strategies and platforms consistent with observed preferences and interests are associated with positive impact on adoption and engagement.
Conclusions and Future Directions
Mobile apps are a new and promising adjunctive, and possibly even stand-alone, treatment option for patients with depression and anxiety disorders. They are technologies that can reach patients beyond the confines of traditional brick-and-mortar clinic visits and engage them directly, in the context of their daily lives. For these reasons, mobile apps are also a unique treatment option to implement, one that requires a thorough understanding of patient perspectives and preferences if effective implementation strategies are to be designed. As reinforced in this study, smart devices are ubiquitous and patients are interested in using this technology. Findings from this study offer several key takeaway points. First, in this sample of individuals with clinically significant mood and/or anxiety symptoms, most were interested in using mobile apps as part of treatment, but few were doing so. Second, participant interest ratings suggest that provider endorsement may positively influence adoption of these technologies. Third, integration of wearables and passive data to direct interventional content, interventions to improve self-care around sleep and inactivity, and common cognitive-behavioral therapy interventions such as cognitive restructuring and behavioral activation were all perceived as valuable by patients. Finally, messaging around these technologies should increase awareness of mobile apps available for this population, relay what is known around efficacy, and address privacy concerns. One way to disseminate these messages could be through patients’ providers, but this would require that providers have easy access to up-to-date information on which apps are efficacious and safe.
Evaluating the generalizability of these findings in a nonveteran sample and determining whether preferences observed here translate to actual behaviors will be critical moving forward. It will also be important to evaluate whether patient interest and concerns are different across various demographic subgroups (eg, gender, race, age, and education) to determine how best to create systems that meet the needs of all segments of the population. Adjusting messaging and implementation strategies in ways that reflect these findings and evaluating patient adoption and engagement are essential next steps. In addition, evaluating whether preferences endorsed translate to preferential use of specific app features in real-world settings could direct attention of app developers toward the features that patients most value.
This study was partially supported by funds made available by the VA Office of Academic Affairs. In addition, Allen Labonte assisted with pulling recruitment data from the VA CDW. Finally, the authors acknowledge 1 key study author, JB, who passed away before the completion of this manuscript. He was an esteemed colleague and is sorely missed by the community.
Conflicts of Interest
Multimedia Appendix 1
Survey questions.PDF File (Adobe PDF File), 84KB
- Pew Research Center. 2018. Mobile Fact Sheet URL: http://www.pewinternet.org/fact-sheet/mobile/ [accessed 2018-11-09] [WebCite Cache]
- IMS Institute for Healthcare Informatics. 2015. Patient Adoption of mHealth: Use evidence and remaining barriers to mainstream acceptance URL: https://www.iqvia.com/-/media/iqvia/pdfs/institute-reports/patient-adoption-of-mhealth.pdf?la=en&hash=B3ACFA8ADDB143F29EAC0C33D533BC5D7AABD689 [accessed 2018-03-22]
- Marcolino MS, Oliveira JA, D'Agostino M, Ribeiro AL, Alkmim MB, Novillo-Ortiz D. The impact of mHealth interventions: systematic review of systematic reviews. JMIR Mhealth Uhealth 2018 Jan 17;6(1):e23 [FREE Full text] [CrossRef] [Medline]
- Liang X, Wang Q, Yang X, Cao J, Chen J, Mo X, et al. Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Diabet Med 2011 Apr;28(4):455-463. [CrossRef] [Medline]
- Bovin MJ, Miller CJ, Koenig CJ, Lipschitz JM, Zamora KA, Wright PB, et al. Veterans' experiences initiating VA-based mental health care. Psychol Serv 2018 May 21 Epub ahead of print(forthcoming). [CrossRef] [Medline]
- Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005 Jun;62(6):617-627 [FREE Full text] [CrossRef] [Medline]
- Cuijpers P, Sijbrandij M, Koole SL, Andersson G, Beekman AT, Reynolds CF. The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry 2013 Jun;12(2):137-148 [FREE Full text] [CrossRef] [Medline]
- Firth J, Torous J, Nicholas J, Carney R, Pratap A, Rosenbaum S, et al. The efficacy of smartphone-based mental health interventions for depressive symptoms: a meta-analysis of randomized controlled trials. World Psychiatry 2017 Oct;16(3):287-298 [FREE Full text] [CrossRef] [Medline]
- Yu JS, Szigethy E, Wallace M, Solano F, Oser M. Implementation of a guided, digital cognitive behavioral program for anxiety in primary care: preliminary findings of engagement and effectivness. Telemed J E Health 2018 Feb 26 Epub ahead of print(forthcoming). [CrossRef] [Medline]
- Mohr DC, Tomasino KN, Lattie EG, Palac HL, Kwasny MJ, Weingardt K, et al. IntelliCare: an eclectic, skills-based app suite for the treatment of depression and anxiety. J Med Internet Res 2017 Jan 05;19(1):e10 [FREE Full text] [CrossRef] [Medline]
- Firth J, Torous J, Nicholas J, Carney R, Rosenbaum S, Sarris J. Can smartphone mental health interventions reduce symptoms of anxiety? A meta-analysis of randomized controlled trials. J Affect Disord 2017 Dec 15;218:15-22 [FREE Full text] [CrossRef] [Medline]
- Torous J, Staples P, Shanahan M, Lin C, Peck P, Keshavan M, et al. Utilizing a personal smartphone custom app to assess the Patient Health Questionnaire-9 (PHQ-9) depressive symptoms in patients with major depressive disorder. JMIR Ment Health 2015 Mar;2(1):e8 [FREE Full text] [CrossRef] [Medline]
- Knowles SE, Toms G, Sanders C, Bee P, Lovell K, Rennick-Egglestone S, et al. Qualitative meta-synthesis of user experience of computerised therapy for depression and anxiety. PLoS One 2014;9(1):e84323 [FREE Full text] [CrossRef] [Medline]
- Shaw H, Ellis DA, Ziegler FV. The Technology Integration Model (TIM). Predicting the continued use of technology. Comput Human Behav 2018 Jun;83:204-214. [CrossRef]
- Venkatesh V, Morris MG, David GB, Davis FD. User acceptance of information technology: toward a unified view. MIS Quarterly 2003;27(3):425. [CrossRef]
- Venkatesh V, Davis FD. A theoretical extension of the Technology Acceptance Model: four longitudinal field studies. Manag Sci 2000 Feb;46(2):186-204. [CrossRef]
- Miller CJ, McInnes DK, Stolzmann K, Bauer MS. Interest in use of technology for healthcare among Veterans receiving treatment for mental health. Telemed J E Health 2016 Dec;22(10):847-854. [CrossRef] [Medline]
- Whealin JM, Seibert-Hatalsky LA, Howell JW, Tsai J. E-mental health preferences of veterans with and without probable posttraumatic stress disorder. J Rehabil Res Dev 2015;52(6):725-738 [FREE Full text] [CrossRef] [Medline]
- Erbes CR, Stinson R, Kuhn E, Polusny M, Urban J, Hoffman J, et al. Access, utilization, and interest in mHealth applications among veterans receiving outpatient care for PTSD. Mil Med 2014 Nov;179(11):1218-1222. [CrossRef] [Medline]
- Nazi KM. The personal health record paradox: health care professionals' perspectives and the information ecology of personal health record systems in organizational and clinical settings. J Med Internet Res 2013 Apr;15(4):e70 [FREE Full text] [CrossRef] [Medline]
- Krebs P, Duncan DT. Health app use among US mobile phone owners: a national survey. JMIR Mhealth Uhealth 2015 Nov;3(4):e101 [FREE Full text] [CrossRef] [Medline]
- Stiles-Shields C, Montague E, Lattie EG, Kwasny MJ, Mohr DC. What might get in the way: barriers to the use of apps for depression. Digital Health 2017 Jun 08;3:e70. [CrossRef]
- Schueller SM, Neary M, O'Loughlin K, Adkins EC. Discovery of and interest in health apps among those with mental health needs: survey and focus group study. J Med Internet Res 2018 Jun 11;20(6):e10141 [FREE Full text] [CrossRef] [Medline]
- Mansell W, Harvey A, Watkins E, Shafran R. Conceptual foundations of the transdiagnostic approach to CBT. J Cogn Psychother 2009 Feb 01;23(1):6-19. [CrossRef]
- Rodriguez BF, Weisberg RB, Pagano ME, Machan JT, Culpepper L, Keller MB. Frequency and patterns of psychiatric comorbidity in a sample of primary care patients with anxiety disorders. Compr Psychiatry 2004 Mar;45(2):129-137 [FREE Full text] [CrossRef] [Medline]
- Chambless DL, Baker-Ericzen MB, Baucom DH, Woody SR. An update on empirically validated therapies. Clin Psychol 1998 Jan;51(1):5-18 [FREE Full text]
- Ballenger JC. Anxiety and depression: optimizing treatments. Prim Care Companion J Clin Psychiatry 2000 Jun;2(3):71-79 [FREE Full text] [Medline]
- Tsao JC, Mystkowski JL, Zucker BG, Craske MG. Effects of cognitive-behavioral therapy for panic disorder on comorbid conditions: replication and extension. Behav Ther 2002;33(4):493-509. [CrossRef]
- Brown C, Schulberg HC, Madonia MJ, Shear MK, Houck PR. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiatry 1996 Oct;153(10):1293-1300. [CrossRef] [Medline]
- Dillman DA. Mail and internet surveys: The tailored design method, 2nd edition. New York, NY: John Wiley & Sons, Inc; 2000.
- Bierman AS, Bubolz TA, Fisher ES, Wasson JH. How well does a single question about health predict the financial health of Medicare managed care plans? Eff Clin Pract 1999;2(2):56-62. [Medline]
- Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord 2009 Apr;114(1-3):163-173. [CrossRef] [Medline]
- Löwe B, Decker O, Müller S, Brähler E, Schellberg D, Herzog W, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care 2008 Mar;46(3):266-274. [CrossRef] [Medline]
- Huguet A, Rao S, McGrath PJ, Wozney L, Wheaton M, Conrod J, et al. A systematic review of cognitive behavioral therapy and behavioral activation apps for depression. PLoS One 2016 May 02;11(5):e0154248. [CrossRef]
- Bakker D, Kazantzis N, Rickwood D, Rickard N. Mental health smartphone apps: review and evidence-based recommendations for future developments. JMIR Ment Health 2016 Mar;3(1):e7 [FREE Full text] [CrossRef] [Medline]
- Schoenfeld DE, Malmrose LC, Blazer DG, Gold DT, Seeman TE. Self-rated health and mortality in the high-functioning elderly--a closer look at healthy individuals: MacArthur field study of successful aging. J Gerontol 1994 May;49(3):M109-M115. [Medline]
- Kroenke K, Spitzer RL, Williams JB. The PHQ-9. J Gen Intern Med 2001 Sep;16(9):606-613. [CrossRef]
- Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006 May 22;166(10):1092-1097. [CrossRef] [Medline]
- Kroenke K, Spitzer RL, Williams JB, Monahan PO, Löwe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007 Mar 06;146(5):317. [CrossRef]
- Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis. CMAJ 2012 Feb 21;184(3):E191-E196 [FREE Full text] [CrossRef] [Medline]
- Dennison L, Morrison L, Conway G, Yardley L. Opportunities and challenges for smartphone applications in supporting health behavior change: qualitative study. J Med Internet Res 2013 Apr;15(4):e86 [FREE Full text] [CrossRef] [Medline]
- Mohr DC, Cuijpers P, Lehman K. Supportive accountability: a model for providing human support to enhance adherence to eHealth interventions. J Med Internet Res 2011 Mar;13(1):e30 [FREE Full text] [CrossRef] [Medline]
- Berger T, Hämmerli K, Gubser N, Andersson G, Caspar F. Internet-based treatment of depression: a randomized controlled trial comparing guided with unguided self-help. Cogn Behav Ther 2011 Dec;40(4):251-266. [CrossRef] [Medline]
- Gilbody S, Littlewood E, Hewitt C, Brierley G, Tharmanathan P, Araya R, et al. Computerised cognitive behaviour therapy (cCBT) as treatment for depression in primary care (REEACT trial): large scale pragmatic randomised controlled trial. Br Med J 2015 Nov 11;351:h5627. [CrossRef]
|CDW: Corporate Data Warehouse|
|GAD-7: Generalized Anxiety Disorder-7|
|mHealth: mobile health|
|PTSD: posttraumatic stress disorder|
|PCP: primary care provider|
|PHQ-8: Patient Health Questionnaire-8|
|VA: Veteran Affairs|
|VHA: Veterans Health Administration|
Edited by C Eichenberg; submitted 18.06.18; peer-reviewed by L Lim, C Fernández, H Baumeister; comments to author 14.07.18; revised version received 21.08.18; accepted 08.09.18; published 25.01.19
©Jessica Lipschitz, Christopher J Miller, Timothy P Hogan, Katherine E Burdick, Rachel Lippin-Foster, Steven R Simon, James Burgess. Originally published in JMIR Mental Health (http://mental.jmir.org), 25.01.2019.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Mental Health, is properly cited. The complete bibliographic information, a link to the original publication on http://mental.jmir.org/, as well as this copyright and license information must be included.